We are live on ! Find out more
Grantham, Mayo, Van Otterloo & Co (GMO)

Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings

AUM $39.1B
1-Year Est. Return 28.69%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$21.2B
AUM Growth
-$3.19B
Cap. Flow
-$4.07B
Cap. Flow %
-19.22%
Top 10 Hldgs %
31.6%
Holding
632
New
70
Increased
110
Reduced
312
Closed
125

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$383M
2
EMC
EMC CORPORATION
EMC
+$348M
3
JNJ icon
Johnson & Johnson
JNJ
+$298M
4
VZ icon
Verizon
VZ
+$211M
5
PFE icon
Pfizer
PFE
+$196M

Sector Composition

Rank Sector Weight
1 Technology 28.28%
2 Healthcare 16.68%
3 Consumer Staples 10.27%
4 Industrials 9.54%
5 Communication Services 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIM
301
Chimera Investment
CIM
$1.06B
$2.88M 0.01%
60,272
+26,672
+79% +$1.31M
GCI
302
DELISTED
Gannett Co., Inc
GCI
$2.83M 0.01%
243,200
-400,398
-62% -$4.98M
TPR icon
303
Tapestry
TPR
$30.3B
$2.78M 0.01%
76,034
-356,398
-82% -$14.1M
EFX icon
304
Equifax
EFX
$22.1B
$2.75M 0.01%
20,445
-149,842
-88% -$19.9M
DD icon
305
DuPont de Nemours
DD
$19B
$2.69M 0.01%
20,494
-56,310
-73% -$7.51M
PLUS icon
306
ePlus
PLUS
$2.43B
$2.68M 0.01%
113,652
-65,712
-37% -$1.43M
MGA icon
307
Magna International
MGA
$18.8B
$2.62M 0.01%
61,200
-69,500
-53% -$2.74M
NVO
308
Novo Nordisk
NVO
$225B
$2.57M 0.01%
123,400
-51,800
-30% -$1.28M
ASRT
309
DELISTED
Assertio
ASRT
$2.56M 0.01%
+1,705
New +$2.14M
CACI icon
310
CACI
CACI
$11.3B
$2.55M 0.01%
25,295
-23,805
-48% -$2.3M
NOC icon
311
Northrop Grumman
NOC
$78.6B
$2.48M 0.01%
11,602
-52,688
-82% -$11.4M
MO icon
312
Altria Group
MO
$125B
$2.43M 0.01%
38,499
-17,201
-31% -$1.14M
TKC icon
313
Turkcell
TKC
$4.79B
$2.43M 0.01%
301,100
-13,600
-4% -$117K
DTE icon
314
DTE Energy
DTE
$30.6B
$2.39M 0.01%
29,960
-210,720
-88% -$17.2M
SYKE
315
DELISTED
SYKES Enterprises Inc
SYKE
$2.39M 0.01%
84,836
-24,886
-23% -$739K
IPG
316
DELISTED
Interpublic Group of Companies
IPG
$2.38M 0.01%
106,727
-404,773
-79% -$9.31M
RDY icon
317
Dr. Reddy's Laboratories
RDY
$9.73B
$2.33M 0.01%
251,000
-150,000
-37% -$1.43M
TXRH icon
318
Texas Roadhouse
TXRH
$13.5B
$2.31M 0.01%
59,307
-227,590
-79% -$10.2M
BKCC
319
DELISTED
BlackRock Capital Investment Corporation
BKCC
$2.31M 0.01%
278,592
-74,696
-21% -$627K
MDP
320
DELISTED
Meredith Corporation
MDP
$2.29M 0.01%
44,014
-38,071
-46% -$2.03M
BAH icon
321
Booz Allen Hamilton
BAH
$8.79B
$2.27M 0.01%
71,734
-594,373
-89% -$18.1M
GYRO icon
322
Gyrodyne
GYRO
$12.3M
$2.27M 0.01%
119,888
HSIC icon
323
Henry Schein
HSIC
$9.74B
$2.18M 0.01%
34,053
-143,894
-81% -$9.55M
ATO icon
324
Atmos Energy
ATO
$30.2B
$2.17M 0.01%
29,116
-155,132
-84% -$11.9M
ICL icon
325
ICL Group
ICL
$6.78B
$2.16M 0.01%
+555,271
New +$2.25M

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)'s Q3 2016 Portfolio in Review

As of Q3 2016, Grantham, Mayo, Van Otterloo & Co (GMO) held 632 positions worth $21.2B, down 13% from $24.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $4.07B in Q3 2016, closing 125 positions and reducing 312 holdings. Its most notable exit was EMC CORPORATION, an estimated $348M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Staples.

Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Cerner Corp worth $79.4M.

  • Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q3 2016 buy was Cerner Corp: 1,285,818 shares worth $79.4M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) added most to Microsoft in Q3 2016, an estimated $140M increase.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q3 2016 reduction was Procter & Gamble, cutting an estimated $383M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) fully exited EMC CORPORATION in Q3 2016, selling an estimated $348M.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 32% of its $21.2B portfolio in Q3 2016.
  • Grantham, Mayo, Van Otterloo & Co (GMO) opened 70 new positions and closed 125 in Q3 2016.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 13% quarter-over-quarter to $21.2B.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2016, filed 10 Nov 2016.